Goat anti- Guinea pig Immunoglobulin G
时间:2013-11-12 阅读:611
-
提供商
上海博麦德生物技术有限公司 -
资料大小
94321 -
资料图片
-
下载次数
86次 -
资料类型
png -
浏览次数
611次
时间:2013-11-12 阅读:611
提供商
上海博麦德生物技术有限公司资料大小
94321资料图片
下载次数
86次资料类型
png浏览次数
611次PRINCIPLE OF THE METHOD
The IgG kit is a solid phase phase sandwich enzyme linked immuno sorbent assay(ELISA). Samples , including standards of known IgG concentrations and unknowns are pipetted into these wells. During the first incubation, the IgG antigen and a biotinylated monoclonal antibody specific for IgG are simultaneously incubated. After washing, the enzyme(streptavidin-peroxydase)is added. After incubation and washing to remove all the unbound enzyme, a substrate solution which is acting on the bound enzyme is added to induce a coloured reaction product. The intensity of this coloured product is directly proportional to the concentration of IgG present in the samples.
REAGENTS PROVIDED AND RECONSTTTUTION
REAGENTS(Store at 2-8℃) | 1×96 WELLS | 0.5×96 WELLS | RECONSTTTUTION |
96/48-wells microtiter plates | 1 | 0.5 | Ready-to-use |
Plastiv cover | 2 | 1 | Ready-to-use |
Standard: 80g/L | 1Vials (0.6ml) | 0.5Vials (0.3ml) | See reagents preparation on page 3 |
Blank control | 1Vials (1.0ml) | 1Vials (0.5ml) | Ready-to-use |
Standard Diluent | 1Vials (5ml) | 1Vials (2.5ml) | Ready-to-use |
Biotinylated anti-IgG | 1Vials (6ml) | 1Vials (3.0ml) | Ready-to-use |
Streptavidin-HRP | 1Vials (10ml) | 1Vials (5.0ml) | Ready-to-use |
Washing Buffer | 1Vials (20ml) | 1Vials (10ml) | 50× concentrate |
Substrate A | 1Vials (6.0ml) | 1Vials (3.0ml) | Ready-to-use |
Substrate B | 1Vials (6.0ml) | 1Vials (3.0ml) | Ready-to-use |
Stopping Solution | 1Vials (6.0ml) | 1Vials (3.0ml) | Ready-to-use |
Sample Diluent | 1Vials (12ml) | 1Vials (6.0ml) | Ready-to-use |
MATERIAL REQUIRED BUT NOT PROVIDED
SAFETY
PROCEDURAL NOTES/LAB.QUALITY CONTROL
SPECIMEN COLLECTION\ PROCESSING AND STORAGE
PREPARATION OF REAGENTS
80 g/L | (6 Standard) | Original density 50ul。 |
40 g/L | (5 Standard) | 100ul 6 Standard +100ul diludent |
20 g/L | (4 Standard) | 100ul 5 Standard +100ul diludent |
10 g/L | (3 Standard) | 100ul 4 Standard +100ul diludent |
5.0 g/L | (2 Standard) | 100ul 3 Standard +100ul diludent |
2.5 g/L | (1 Standard) | 100ul 2 Standard +100ul diludent |
0 g/L | Blank Control | 50ul。 |
ASSAY METHOD
SUGGESTED PLATE SCHEME
| Standard concentrations(g/L) |
| ||||||||||
A | 80 | 80 | sample | sample | sample | sample | sample | sample | sample | sample | sample | sample |
B | 40 | 40 | sample | sample | sample | sample | sample | sample | sample | sample | sample | sample |
C | 20 | 20 | sample | sample | sample | sample | sample | sample | sample | sample | sample | sample |
D | 10 | 10 | sample | sample | sample | sample | sample | sample | sample | sample | sample | sample |
E | 5.0 | 5.0 | sample | sample | sample | sample | sample | sample | sample | sample | sample | sample |
F | 2.5 | 2.5 | sample | sample | sample | sample | sample | sample | sample | sample | sample | sample |
G | 0 | 0 | sample | sample | sample | sample | sample | sample | sample | sample | sample | sample |
H | sample | sample | sample | sample | sample | sample | sample | sample | sample | sample | sample | sample |
LIMITATIONS OF THE PROCEDURE
Do not extrapolate the standard curve beyond the max standard curve point. The dose-response is non-linear in this region and good accruacy is difficult to obtain.
CALCULATION OF RESULTS
The minimum detectable concentration in this assay is estimated to be 0.1g/L